283 related articles for article (PubMed ID: 30826396)
1. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
[TBL] [Abstract][Full Text] [Related]
2. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
4. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
6. CHN1 promotes epithelial-mesenchymal transition via the Akt/GSK-3β/Snail pathway in cervical carcinoma.
Zhao H; Wang L; Wang S; Chen X; Liang M; Zhang X; Wang J; Xu X
J Transl Med; 2021 Jul; 19(1):295. PubMed ID: 34238315
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-κB signaling.
Xu H; Xiao Q; Fan Y; Xiang T; Li C; Li C; Li S; Hui T; Zhang L; Li H; Li L; Ren G
Cancer Med; 2017 Jun; 6(6):1399-1408. PubMed ID: 28503860
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
[TBL] [Abstract][Full Text] [Related]
10. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS
Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361
[TBL] [Abstract][Full Text] [Related]
11. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.
Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P
BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937
[TBL] [Abstract][Full Text] [Related]
13. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
[TBL] [Abstract][Full Text] [Related]
14. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer.
Bhat S; Kabekkodu SP; Adiga D; Fernandes R; Shukla V; Bhandari P; Pandey D; Sharan K; Satyamoorthy K
Cell Biol Toxicol; 2021 Oct; 37(5):731-749. PubMed ID: 33566221
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
16. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
[TBL] [Abstract][Full Text] [Related]
17. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
18. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
19. Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
He JH; Chen JG; Zhang B; Chen J; You KL; Hu JM; Xu JW; Chen L
Technol Cancer Res Treat; 2020; 19():1533033820936773. PubMed ID: 32618228
[TBL] [Abstract][Full Text] [Related]
20. α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.
An HT; Yoo S; Ko J
Oncogene; 2016 Nov; 35(45):5893-5904. PubMed ID: 27065319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
